Evidence map›Paper›PMID 25254480›Full record

ArticleNature2014

Mitochondrial Ca2+ uniporter and CaMKII in heart.

Francesca Fieni, Derrick E Johnson, Andy Hudmon, Yuriy Kirichok

Abstract readLetterComment
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. CaMKII as a Therapeutic Target in Cardiovascular Disease.Annual review of pharmacology and toxicology · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. CaPflugers Archiv : European journal of physiology · 2022
    Review
  11. Review
  12. CaMKIIδ Splice Variants in the Healthy and Diseased Heart.Frontiers in cell and developmental biology · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Regulation of Mitochondrial ATP Production: CaTrends in molecular medicine · 2020
    Review
  18. Review
  19. Role of mitochondrial CaArchives of biochemistry and biophysics · 2019
    Review
  20. Crosstalk between Calcium and ROS in Pathophysiological Conditions.Oxidative medicine and cellular longevity · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Francesca FieniDepartment of Physiology, University of California San Francisco, San Francisco, California 94158, USA.
Derrick E JohnsonDepartment of Biochemistry and Molecular Biology, Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Andy HudmonDepartment of Biochemistry and Molecular Biology, Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Yuriy KirichokDepartment of Physiology, University of California San Francisco, San Francisco, California 94158, USA.

Funding

CaMKII in neuronal signaling and degenerationR01NS078171 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI CUMMINS, THEODORE R, HUDMON, ANDY · 2012 to 2015
$1.3M
NINDS NIH HHS R01 NS078171
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Stress, PhysiologicalAnimalsCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2FemaleMitochondria, HeartMyocardiumCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2

Identifiers

PMID25254480
PMCPMC4476531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.